The Journal is included in Russian and International Library and Abstract Databases
Russain Science Index (Russia)
EBSCO
DOI Registration Agency (USA)
Scientific Indexing Services (USA)
CAS Source index (USA)
Web of Science Group (USA)

ASSESMENT OF THE POSSIBILITY OF RELEASE OF FREE GOSSYPOL FROM KAGOCEL UNDER THE INFLUENCE OF HUMAN DIGESTIVE JUICE SIMULANTS

DOI: https://doi.org/None
Issue: 
5
Year: 
2017

Professor A.P. Sinitsin (1), PhD; V.P. Khotchenkov (1), PhD; Professor B.A. Rudoy (2), PhD; Yu.G. Kazaishvili (2), PhD 1-Federal Research Center of Biotechnology, Russian Academy of Sciences; 33, Leninsky Prospect, Build. 2, Moscow 119071, Russian Federation; 2-NEARMEDIC PLUS; 12, Aircraft Designer Mikoyan St., Moscow 125252, Russian Federation

Introduction. Kagocel (12-mg tablets) has been designed on the basis of an oxidized cellulose polymer with grafted chemically modified molecules of the natural polyphenol gossypol. When this natural highly biologically active polyphenol is in a bound state, it loses its toxicity, by maintaining its beneficial pharmacological properties. The manufacture of Kagocel ensures thorough removal of unbounded free gossypol residues and control of the presence of the latter. Lack of toxic effects of Kagocel has been confirmed by preclinical studies. In addition, the safety of the drug can be proved by the fact that free gossypol cannot be released from the active substance of the drug in the human body under the influence of digestive juices. Objective: to estimate the content of free gossypol in Kagocel after exposure to standard model environments, such as human gastric and intestinal juice simulants, as well as after incubation of the drug in the medium containing active microbial cellulase. Material and methods. The investigation object was 12-mg tablets of Kagocel. The highly sensitive method, namely: high-performance liquid chromatography with mass spectrometric detection (HPLC-MS) was used to monitor and quantify free gossypol as part in the model media. Results. The highly sensitive and highly specific HPLC-MS procedure was developed and validated to determine minimal quantities of residual free gossypol in Kagocel (12-mg tablets). The procedure allows reliable detection of free gossypol at solution concentrations in the range of 0.005 to 2.500 µg/ml. The content of traces as free gossypol in the medium after 24-hour incubation in standard gastric and intestinal juice simulants, as well as after exposure to microbial cellulase did not increase. Conclusion. The release and accumulation of free gossypol do not occur after prolonged incubation of Kagocel in both simulation and microbial cellulase-containing environments.

Keywords: 
Kagocel
gossypol
model media
high-performance liquid chromatography
validation

References: 
  1. Wang X., Howell C.P., Chen F., Yin J., Jiang Y. Gossypol-a polyphenolic compound from cotton plant. Advances in food and nutrition research. 2009. Vol. 58: 215–63.
  2. Zhang W.J., Xu Z.R., Pan X.L., Yan X.H., Wang Y.B. Advances in gossypol toxicity and processing effects of whole cottonseed in dairy cows feeding. Livestock Science 111.1 (2007): 1–9.
  3. Hongxia Lin, Gounder M. K., Bertino J.R., Ah-Ng Tony Kong, DiPaola R.S., Steina M.N. A validated HPLC assay for the determination of R-(–)-gossypol in human plasma and its application in clinical pharmacokinetic studies //Journal of pharmaceutical and biomedical analysis. – 2012. – Vol. 66.:371–5
  4. Yingfan Cai, Hong Zhang, Yu Zeng, Jianchuan Mo, Jinku Bao, Chen Miao, Jie Bai, Fang Yan and Fang Chen. An optimized gossypol high-performance liquid chromatography assay and its application in evaluation of different gland genotypes of cotton. Journal of Biosciences. 2004. Vol. 29, 1: 67–71.
  5. Chandrashekar R., Karunakar Rao Kudle, Jyothi Chaitanya P. and Lakshmi Bhavani N.. Gossypol analysis in Bt and non-Bt cotton seed extracts by high-performance liquid chromatography (HPLC). International journal of herbal medicine. 2013. Vol. 1, 2: 53–8.
  6. Khodwe M. S., Bhowmick D. N. Separation of gossypol from cottonseed and preparation of gossypol-free cottonseed cake. International Journal of Recent Scientific Research. 2013. Vol. 4, 8: 1290–5.
  7. Kiseleva I.V., Rudoy B.A., Pirogov A.V., Tolmacheva N.G. Validaciya VE`ZhH-metodiki opredeleniya gossipola v substancii «Kagocel». Farmaciya. 2016. T. 65, 8: 18–24. [ Kiseleva I.V., Rudoi B.A., Pirogov A.V., Tolmacheva N.G. Validation of an HPLC method of evaluation of gossypol in the substance of «Kagocel». Farmatsiya. 2016. Vol. 65, 8: 18-24] (in Russian)].
  8. Gosudarstvennaya farmakopeya Rossiyskoy Federacii. XIII izdanie. T.1. M., 2015: 178–87. [State Pharmacopeia of the Russian Federation, XIII-th ed. Vol.1. Moscow., 2015: 178–87 (in Russian)].
  9. Scientific opinion. Gossypol as undesirable substance in animal feed. The EFSA Journal, 2008; 908: 1–55.
  10. Klein S. The use of biorelevant dissolution media to forecast the in vivo performance of a drug. The AAPS journal. 2010. Vol. 12, 3: 397–406.
  11. USP Dissolution Methods Database Updated Mar 2, 2017, with the release of the First Suppl. of USP 40 – NF 35
  12. Recommendations on methods for dosage forms testing European Pharmacopoeia 7.0 Vol: 665–6.
  13. Agrocell. Instrukciya po primeneniyu. 2012. [Agrocell. Instruction for users. 2012 (in Russian)].
  14. Nomeir A.A., Abou-Donia M.B. Gossypol: High-Performance Liquid Chromatographic Analysis and Stability in Various Solvents. JAOCS. 1982.Vol. 59, 12: 547
  15. Kenar J. A. Reaction chemistry of gossypol and its derivatives. Journal of the American Oil Chemists' Society. 2006. Vol. 83, 4: 269–302.
  16. Nomeir A.A., Abou-Donia M.B. Photodecomposition of Gossypol by Ultraviolet Irradiation. JAOCS. 1985. Vol. 62: 1.
  17. Gossypol and its derivatives and their complexes in solutions. Ziyaev Kh. L., Baram N.I., Khodzhaniyazov B., Kamaev F.G., Biktlmirov L., Dzhurabekova S.B. , Ismailov A.I. Chemistry of Natural Compounds. 1998. Vol. 34, 1: 52–6.
  18. Assessment of enzymatic prodrug stability in human, dog and simulated intestinal fluids. Borde A.S, Karlsson E.M., Andersson K, Björhall K, Lennernäs H, Abrahamsson B. Eur J Pharm Biopharm. 2012. Vol. 80(3):630-7.